• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    35.08 Up 1.36(4.03%) Jul 31, 4:00PM EDT
    |After Hours : 35.08 0.00 (0.00%) Jul 31, 5:36PM EDT
    Add to Portfolio
    Prev Close:33.72
    Open:33.56
    Bid:35.07 x 1200
    Ask:35.08 x 200
    1y Target Est:7.35
    Beta:1.71
    Next Earnings Date:10-Aug-15CHRS Earnings announcement
    Day's Range:33.56 - 35.60
    52wk Range:12.38 - 38.10
    Volume:147,150
    Avg Vol (3m):319,086
    Market Cap:1.33B
    P/E (ttm):N/A
    EPS (ttm):-6.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CHRS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):38.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jan-13) :N/A
    Quarterly EPS Est (Jul-12) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback